Two foreign companies contracted to develop diagnostic centre for oncology services at Hulhumalé Hospital on October 29, 2026. (Photo/Hulhumale' Hospital)
The Malé City Group of Hospitals (MCGH) has signed a Memorandum of Understanding (MoU) with two foreign companies to establish a diagnostic centre for oncology services at Hulhumalé Hospital.
The project will be undertaken through a joint venture between UK-based Quantum Heights and India-based Vascular Technology.
MCGH CEO Ibrahim Abdul Razzaq Haleem signed the agreement on behalf of the group, while Chief Operating Officer and Director Chintan Soni signed on behalf of the contractor. The signing ceremony was attended by Health Minister Geela Ali senior Ministry officials and executive staff from the Malé City Group of Hospitals.
Although several hospitals in the Maldives currently provide certain cancer-related surgeries and chemotherapy, critical treatments such as radiation therapy and nuclear medicine, as well as PET-CT scans, are not yet available at government hospitals.
Haleem said the establishment of the centre would reduce the country’s reliance on overseas treatment and provide significant financial and psychological relief to families.
“Our objective is to establish a specialized center that provides early diagnosis, specialized treatment, clinical monitoring, and supportive care under one roof, allowing patients to remain close to their families and loved ones,” he said.
He added that the centre would provide comprehensive services, from diagnosis to follow-up care, guided by a tumour board comprising experts from various medical fields.
Advancing Cancer Care in the Maldives ???????? As part of the healthcare development commitments announced in the 2026 Presidential Address, MCGH has signed a MoU towards establishing the Diagnostic Centre for Oncology Services (DCOS) @presidencymv @MoHmv https://t.co/4iRq8t0yW5
— Hulhumalé Hospital (@HMH_mv) October 28, 2026
Haleem also highlighted that the facility would offer radiation therapy using the latest IMRT, 3D-CRT and IGRT technologies, alongside diagnostic services such as CT simulation and pathology. The centre will also include inpatient wards, specialised oncology operating theatres, chemotherapy units, psychological support and other supportive care services.
Haleem added that plans were underway to train Maldivian doctors, nurses, physicists and radiologists in the field with support from international partners.
MCGH plans to implement the project in phases, with the aim of completing the centre and commencing services by 2028.